gip/glp-1 agonists Glucagon-like peptide-1 (GLP-1) receptor are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic Targeting GLP-1, GIP & GCG

Interestingly, glucagon-like peptide-1 receptor agonists (GLP-1RAs), used in the treatment of T2DM and obesity, are known to show pro-cognitive and neuroprotective properties, and exert modulatory effects on immune, endocrine and metabolic processes in the central nervous system

For individuals of Asian descent, a BMI Current Strategies in Managing Obesity Read More

%Daily Value

Learn safe medication injection storage tips to protect your GLP-1 treatment, maintain potency, and ensure safe, effective results.

In recent years, there has been an increase in the morbidity, disability rate,and mortality due to obesity, making ...